Skip to main content

Table 1 Clinical and epidemiological characteristics of HCV-infected patients

From: CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study

Characteristics

Data

No.

389

Male sex

228 (58.6%)

Age (years)

49.6 (43.2; 57.7)

Time of HCV diagnosis (years)

8.6 (2.1; 14.1)

High alcohol intake

75 (19.3%)

Prior injection drug use

66 (17%)

HCV genotype (n = 383)

 1

311 (81.2%)

 2

5 (1.3%)

 3

42 (11%)

 4

23 (6%)

 5

2 (0.5%)

Non-responder (peg-IFN-α/RBV)

81 (20.8%)

Liver stiffness (kPa)

6.9 (5.5; 10.5)

 F0–F1 (<7.1)

205 (52.7%)

 F2 (7.1–9.4)

65 (16.7%)

 F3 (9.5–12.4)

48 (12.3%)

 F4.1 (12.5–21.4)

41 (10.5%)

 F4.2 (≥21.5)

30 (7.7%)

  1. Values expressed as absolute numbers (%) and median (percentile 25; percentile 75)
  2. HCV hepatitis C virus, LSM liver stiffness measure, kPa kilopascal, IFN interferon, peg-IFN-α/RBV pegilated-interferon-alpha/ribavirin